The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)

A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis

(2022) Amar Miglani et al.   International Forum of Allergy & Rhinology

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

(2021) Claire Hopkins et al.   International Forum of Allergy & Rhinology

Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps

(2021) Joseph K. Han et al.   International Forum of Allergy & Rhinology

Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps

(2020) George A. Scangas et al.   LARYNGOSCOPE

International Consensus Statement on Rhinology and Allergy: Rhinosinusitis

(2020) Richard R. Orlandi et al.   International Forum of Allergy & Rhinology

EUFOREA Consensus on Biologics for CRS w NP with or without asthma

(2019) W J Fokkens et al.   ALLERGY

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

(2019) Claus Bachert et al.   LANCET

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

(2018) Mario Castro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cognitive biases associated with medical decisions: a systematic review

(2016) Gustavo Saposnik et al.   BMC Medical Informatics and Decision Making